Mechanisms of penile fibrosis

Journal of Sexual Medicine

Volumn 6, Issue SUPPL. 3, 2009, Pages 353-362

  Gonzalez Cadavid, Nestor F ^a,b  

^a LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Corporal veno occlusive dysfunction; Erectile dysfunction; Inducible nitric oxide synthase

Indexed keywords

COLLAGEN FIBER; CYCLIC GMP; NITRIC OXIDE; PIOGLITAZONE; SILDENAFIL; TADALAFIL; VARDENAFIL;

CELL DIFFERENTIATION; COLLAGEN METABOLISM; CONFERENCE PAPER; ERECTILE DYSFUNCTION; EXTRACELLULAR MATRIX; FIBROBLAST; HISTOPATHOLOGY; HUMAN; MEDLINE; MYOFIBROBLAST; NONHUMAN; PATHOPHYSIOLOGY; PENILE FIBROSIS; PEYRONIE DISEASE; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; STEM CELL; STEM CELL TRANSPLANTATION; TUNICA ALBUGINEA; VEIN OCCLUSION;

EID: 61849137692     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2008.01195.x     Document Type: Conference Paper

References (68)

1. Qian Y, Feldman E, Pennathur S, Kretzler M, Brosius FC 3rd. From fibrosis to sclerosis: Mechanisms of glomerulosclerosis in diabetic nephropathy. Diabetes 2008; 57: 1439-45.
2. Toblli JE, Ferrini MG, Cao G, Vernet D, Angerosa M, Gonzalez-Cadavid NF. Antifibrotic effects of pioglitazone on the kidney in a rat model of type 2 diabetes mellitus. Diabetes submitted abstract: National Kidney Foundation (NKF) 2008 Spring Clinical Meetings, Dallas, Texas.
3. Lee JY, Stenzel W, Impekoven P, Theisohn M, Stützer H, Löhr M, Reithmeier T, Ernestus RI, Ebel H, Klug N. The effect of mitomycin C in reducing epidural fibrosis after lumbar laminectomy in rats. J Neurosurg Spine 2006; 5: 53-60.
4. Gonzalez-Cadavid NF, Rajfer J. Mechanisms of disease: New insights into the cellular and molecular pathology of Peyronie's disease. Nat Clin Pract Urol 2005; 2: 291-8.
5. Burnett AL, Bivalacqua TJ. Priapism: Current principles and practice. Urol Clin North Am 2007; 34: 631-42.
6. Iacono F, Giannella R, Somma P, Manno G, Fusco F, Mirone V. Histological alterations in cavernous tissue after radical prostatectomy. J Urol 2005; 173: 1673-6.
7. Schwartz EJ, Wong P, Graydon RJ. Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy. J Urol 2004; 171: 771-4.
8. Rambhatla A, Kovanecz I, Ferrini M, Gonzalez-Cadavid NF, Rajfer J. Rationale for phosphodiesterase 5 inhibitor use post-radical prostatectomy: Experimental and clinical review. Int J Impot Res 2008; 20: 30-4.
9. Ferrini MG, Kovanecz I, Sanchez S, Vernet D, Davila HH, Rajfer J, Gonzalez-Cadavid NF. Long-term continuous treatment with sildenafil ameliorates aging-related erectile dysfunction and the underlying corporal fibrosis. Biol Reprod 2007; 76: 915-23.
10. Ferrini MG, Davila H, Valente EG, Gonzalez-Cadavid NF, Rajfer J. Aging-related induction of inducible nitric oxide synthase (iNOS) is vasculo-protective in the arterial media. Cardiovasc Res 2004; 61: 796-805.
11. Davila H, Ferrini M, Rajfer J, Gonzalez-Cadavid NF. Fibrin induction of a Peyronie's-like plaque in the rat penile tunica albuginea. A new model for Peyronie's disease. Br J Urol 2003; 91: 830-8.
12. Somers KD, Dawson DM. Fibrin deposition in Peyronie's disease plaque. J Urol 1997; 157: 311-5.
13. Klein LT, Miller MI, Buttyan R, Raffo AJ, Burchard M, Devris G, Cao YC, Olsson C, Shabsigh R. Apoptosis in the rat penis after penile denervation. J Urol 1997; 158: 626-30.
14. User HM, Hairston JH, Zelner DJ, McKenna KE, McVary KT. Penile weight and cell subtype specific changes in a post-radical prostatectomy model of erectile dysfunction. J Urol 2003; 169: 1175-9.
15. Leungwattanakij S, Bivalacqua TJ, Usta MF, Yang DY, Hyun JS, Champion HC, Abdel-Mageed AB, Hellstrom WJ. Cavernous neurotomy causes hypoxia and fibrosis in rat corpus cavernosum. J. Androl 2003; 24: 239-49.
16. Ferrini MG, Davila H, Kovanecz I, Sanchez S, Gonzalez-Cadavid NF, Rajfer J. Long-term continuous treatment with vardenafil prevents fibrosis and preserves smooth muscle content in the rat corpora cavernosa after bilateral cavernosal nerve transaction. Urology 2006; 68: 429-35.
17. Kovanecz I, Rambhatla A, Ferrini MG, Vernet D, Sanchez S, Rajfer J, Gonzalez-Cadavid NF. Long term sildenafil treatment ameliorates corporal veno-occlusive dysfunction (CVOD) induced by cavernosal nerve resection in rats. Int J Impot Res 2007; 100: 867-74.
18. Kovanecz I, Rambhatla A, Ferrini MG, Vernet D, Sanchez S, Rajfer J, Gonzalez-Cadavid NF. Chronic daily tadalafil prevents the corporal fibrosis and veno-occlusive dysfunction (CVOD) that occurs following cavernosal nerve resection in the rat. BJU Int 2008; 101: 203-10.
19. Ferrini MG, Kovanecz I, Sanchez S, Vernet D, Umeh C, Rajfer J, Gonzalez-Cadavid NF. Fibrosis and loss of smooth muscle in the corpora cavernosa precede corporal veno-occlusive dysfunction (CVOD) induced by experimental cavernosal nerve damage in the rat. J Sex Med 2008 (in press).
20. Garban H, Vernet D, Freedman A, Rajfer J, Gonzalez-Cadavid NF. Effect of aging on nitric oxide-mediated penile erection in the rat. Am J Physiol 1995; 268: H467-75.
21. Ferrini M, Magee TR, Vernet D, Rajfer J, Gonzalez-Cadavid NF. Aging-related expression of inducible nitric oxide synthase (iNOS) and markers of tissue damage in the rat penis. Biol Reprod 2001; 64: 974-82.
22. Kovanecz I, Ferrini MG, Davila HH, Rajfer J, Gonzalez-Cadavid NF. Pioglitazone ameliorates penile corpora veno-occlusive dysfunction (CVOD) in the aged rat. BJU Int 2007; 100: 867-74.
23. Kovanecz I, Ferrini MG, Vernet D, Nolazco G, Rajfer J, Gonzalez-Cadavid NF. Pioglitazone prevents corporal veno-occlusive dysfunction (CVOD) in a rat model of type 2 diabetes mellitus. BJU Int 2006; 98: 116-24.
24. Kovanecz I, Nolazco G, Ferrini MG, Toblli JE, Heydarkhan S, Vernet D, Rajfer J, Gonzalez-Cadavid NF. Early onset of fibrosis within the arterial media in a rat model of type 2 diabetes mellitus exhibiting erectile dysfunction. BJU Int 2008 (in press).
25. Nolazco G, Kovanecz I, Vernet D, Ferrini M, Gelfand B, Tsao J, Magee T, Rajfer J, Gonzalez-Cadavid NF. Effect of muscle derived stem cells on the restoration of corpora cavernosa smooth muscle and erectile function in the aged rat. BJU Int 2008; 101: 1156-64.
26. Dávila HH, Ferrini MG, Magee TR, Rajfer J, González-Cadavid NF. Detrimental effect of cigarette smoking on erectile dysfunction in the rat is contingent to diabetes as co-morbidity. J Urol 2004; 171: 374 (#1420).
27. Broderick GA. Evidence based assessment of erectile dysfunction. Int J Impot Res 1998; 10: (2 suppl): S64-73; discussion S77-9.
28. Davila HH, Rajfer J, Gonzalez-Cadavid NF. Corporal veno-occlusive dysfunction in the aging rat. Evaluation by cavernosometry and cavernosography. Urology 2004; 64: 1261-6.
29. Aneja A, Tang WH, Bansilal S, Garcia MJ, Farkouh ME. Diabetic cardiomyopathy: Insights into pathogenesis, diagnostic challenges, and therapeutic options. Am J Med 2008; 121: 748-57.
30. Sun Y. Oxidative stress and cardiac repair/remodeling following infarction. Am J Med Sci 2007; 334: 197-205.
31. Svegliati-Baroni G, De Minicis S, Marzioni M. Hepatic fibrogenesis in response to chronic liver injury: Novel insights on the role of cell-to-cell interaction and transition. Liver Int 2008; 28: 1052-64.
32. Nagai S, Handa T, Kim D. Pharmacotherapy in patients with idiopathic pulmonary fibrosis. Expert Opin Pharmacother 2008; 9: 1909-25.
33. Darby IA, Hewitson TD. Fibroblast differentiation in wound healing and fibrosis. Int Rev Cytol 2007; 257: 143-79.
34. Gonzalez-Cadavid NF, Rajfer J. Experimental models for Peyronie's disease. Implications for therapy. J Sex Med 2008 (in press).
35. Mulhall JP, Nicholson B, Pierpaoli S, Lubrano T, Shankey TV. Chromosomal instability is demonstrated by fibroblasts derived from the tunica of men with Peyronie's disease. Int J Impot Res 2004; 16: 288-93.
36. Mulhall JP, Branch J, Lubrano T, Shankey TV. Perturbation of cell cycle regulators in Peyronie's disease. Int J Impot Res 2001; 13 (5 suppl): S21-8.
37. Bivalacqua TJ, Diner EK, Novak TE, Vohra Y, Sikka SC, Champion HC, Kadowitz PJ, Hellstrom WJ. A rat model of Peyronie's disease associated with a decrease in erectile activity and an increase in inducible nitric oxide synthase protein expression. J Urol 2000; 163: 1992-8.
38. Ferrini MG, Vernet D, Magee TR, Shahed A, Quian A, Rajfer J, Gonzalez-Cadavid NF. Antifibrotic role of inducible nitric oxide synthase (iNOS). Nitric Oxide 2002; 6: 283-94.
39. Vernet D, Ferrini MG, Valente E, Magee TR, Bou-Gharios G, Rajfer J, Gonzalez-Cadavid NF. Effect of nitric oxide on the differentiation of fibroblasts into myofibroblasts in the Peyronie's fibrotic plaque and in its rat model. Nitric Oxide 2002; 7: 262-76.
40. Davila H, Magee TR, Rajfer J, Gonzalez-Cadavid NF. Peyronie's disease is associated with an increase of plasminogen activator inhibitor-1 (PAI-1) at the RNA and protein levels. Urology 2005; 65: 645-8.
41. Gonzalez-Cadavid NF, Rajfer J. Molecular and cellular aspects of the pathophysiology of Peyronie's disease. Drug Discov Today Dis Mech 2004; 1: 99-106.
42. Davila HH, Magee TR, Rajfer J, Gonzalez-Cadavid NF. Gene therapy with the inducible nitric oxide synthase (iNOS) cDNA regresses the fibrotic plaque in an animal model of Peyronie's disease. Biol Reprod 2004; 71: 1568-77.
43. Vernet D, Qian A, Nolazco G, Cantini L, Magee TR, Ferrini MG, Rajfer J, Gonzalez-Cadavid NF. Evidence that osteogenic progenitor cells in the human tunica albuginea may originate from stem cells. Implications for Peyronie's disease. Biol Reprod 2005; 73: 1199-210.
44. Magee TR, Qian A, Rajfer J, Levine L, Gonzalez-Cadavid NF. Gene expression profiles in the Peyronie's disease plaque. Urology 2002; 59: 451-7.
45. Qian A, Meals R, Rajfer J, Gonzalez-Cadavid NF. Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture. Urology 2004; 64: 399-404.
46. Valente EG, Vernet D, Ferrini MG, Qian A, Rajfer J, Gonzalez-Cadavid NF. L-arginine and PDE inhibitors counteract fibrosis in Peyronie's plaque and related fibroblast cultures. Nitric Oxide 2003; 9: 229-44.
47. Ferrini MG, Kovanecz I, Nolazco G, Rajfer J, Gonzalez-Cadavid NF. Effects of long-term treatment with vardenafil on the development of the fibrotic plaque in a rat model of Peyronie's disease. BJU Int 2006; 97: 625-33.
48. Vernet D, Magee TR, Qian A, Rajfer J, Gonzalez-Cadavid NF. Long-term continuous incubation with high doses of tadalafil does not up-regulate the levels of phosphodiesterase 5 (PDE5) in cultures of human penile smooth muscle cells. J Sex Med 2006; 3: 84-94, discussion 94-5.
49. Cantini LP, Ferrini MG, Vernet D, Magee TR, Quian A, Gelfand RA, Rajfer J, Gonzalez-Cadavid NF. Pro-fibrotic role of myostatin in Peyronie's disease. J Sex Med 2008; 5: 1607-22.
50. Ferrini MG, Nolazco G, Vernet D, Gonzalez-Cadavid NF, Berman J. Increased vaginal oxidative stress, apoptosis, and inducible nitric oxide synthase in a diabetic rat model: Implications for vaginal fibrosis. Fertil Steril 2006; 86: 1152-63.
51. Gonzalez-Cadavid NF, Rajfer J. The pleiotropic effects of inducible nitric oxide synthase on the physiology and pathology of penile erection. Curr Pharm Des 2005; 11: 4041-6.
52. Ferrini M, Sanchez S, Vernet D, Kovanecz I, Rajfer J, Gonzalez-Cadavid NF. Age-independent penile fibrosis in the inducible nitric oxide synthase knock-out (iNOS ko) mouse supports the antifibrotic role of iNOS. Soc Sex Medcin Nort Am Meeting, New York, NY, 2006.
53. Ferrini MG, Vernet D, Rivera S, Rajfer J, Gonzalez-Cadavid NF. Genetic blockade of iNOS intensifies fibrosis of the penile corpora cavernosa associated with type 1 diabetes in the iNOS knock out mouse. Abstract to be submitted to the next AUA meeting, Chicago, 2008.
54. Mulhall JP, Müller A, Donohue JF, Mullerad M, Kobylarz K, Paduch DA, Tal R, Li PS, Cohen-Gould L, Scardino PT. The functional and structural consequences of cavernous nerve injury are ameliorated by sildenafil citrate. J Sex Med 2008; 5: 1126-36.
55. Aziz MT, Mostafa T, Atta H, Rashed L, Marzouk SA, Obaia EM, Sabry D, Hassouna AA, El Shehaby AM, Aziz AT. The role of PDE5 inhibitors in heme oxygenase-cGMP relationship in rat cavernous tissues. J Sex Med 2008; 5: 1636-45.
56. Fandel TM, Bella AJ, Lin G, Tantiwongse K, Lin CS, Pohl J, Lue TF. Intracavernous growth differentiation factor-5 therapy enhances the recovery of erectile function in a rat model of cavernous nerve injury. J Sex Med 2008; 5: 1866-75.
57. Mulhall JP, Müller A, Donohue JF, Golijanin D, Tal R, Akin-Olugbade Y, Kobylarz K, Cohen-Gould L, Bennett NE, Scardino P. FK506 and erectile function preservation in the cavernous nerve injury model: Optimal dosing and timing. J Sex Med 2008; 5: 1334-44.
58. Pu XY, Wang XH, Gao WC, Yang ZH, Li SL, Wang HP, Wu YL. Insulin-like growth factor-1 restores erectile function in aged rats: Modulation the integrity of smooth muscle and nitric oxide-cyclic guanosine monophosphate signaling activity. J Sex Med 2008; 5: 1345-54.
59. Song YS, Lee HJ, Park IH, Kim WK, Ku JH, Kim SU. Potential differentiation of human mesenchymal stem cell transplanted in rat corpus cavernosum toward endothelial or smooth muscle cells. Int J Impot Res 2007; 19: 378-85.
60. Bivalacqua TJ, Deng W, Kendirci M, Usta MF, Robinson C, Taylor BK, Murthy SN, Champion HC, Hellstrom WJ, Kadowitz PJ. Mesenchymal stem cells alone or ex vivo gene modified with endothelial nitric oxide synthase reverse age-associated erectile dysfunction. Am J Physiol Heart Circ Physiol 2007; 292: H1278-90.
61. Lin G, Hayashi N, Carrion R, Chang LJ, Lue TF, Lin CS. Improving erectile function by silencing phosphodiesterase-5. J Urol 2005; 174: 1142-8.
62. Artaza JN, Singh R, Ferrini MG, Braga M, Tsao J, Gonzalez-Cadavid NF. Myostatin promotes a fibrotic phenotypic switch in multipotent C3h 10T1/ 2 cells without affecting their differentiation into myofibroblasts. J Endocrinol 2008; 196: 235-49.
63. Magee TR, Artaza JN, Ferrini MG, Zuniga FI, Cantini L, Reisz-Porszasz S, Rajfer J, Gonzalez-Cadavid NF. Myostatin shRNA gene therapy increases muscle mass. J Gene Med 2006; 8: 1171-81.
64. Zhang LW, Piao S, Choi MJ, Shin HY, Jin HR, Kim WJ, Song SU, Han JY, Park SH, Mamura M, Kim SJ, Ryu JK, Suh JK. Role of increased penile expression of transforming growth factor-beta1 and activation of the smad signaling pathway in erectile dysfunction in streptozotocin-induced diabetic rats. J Sex Med 2008 [Epub ahead of print].
65. Atkinson JJ, Senior RM. Matrix metalloproteinase-9 in lung remodeling. Am J Respir Cell Mol Biol 2003; 28: 12-24.
66. Ho MH, Heydarkhan S, Vernet D, Kovanecz I, Ferrini MG, Bhatia NN, Gonzalez-Cadavid NF. Skeletal muscle-derived stem cells (MDSC) seeded on small intestinal submucosal (SIS) scaffolds stimulate vaginal repair in the rat. J Urol 2008; 179: 46B. (A1369).
67. Lowry WE, Richter L, Yachechko R, Pyle AD, Tchieu J, Sridharan R, Clark AT, Plath K. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci U S A 2008; 105: 2883-8.
68. Ratajczak MZ, Zuba-Surma EK, Shin DM, Ratajczak J, Kucia M. Very small embryonic-like (VSEL) stem cells in adult organs and their potential role in rejuvenation of tissues and longevity. Exp Gerontol 2008 [Epub ahead of print].